Hemostatic Factors Have Potential as Biomarkers and Therapeutic Targets in MS
The Martinos Center’s Caterina Mainero, MD, PhD and colleagues reviewed the interplay of fibrinogen and coagulation factors with neuroinflammation in multiple sclerosis. They conclude that basic knowledge of the coagulation pathways could be translated into new treatment approaches and novel diagnostic and prognostic biomarkers.